Sumitomo Pharma America, Inc.
Senior Vice President/Head Cell Therapy
Blair McNeill is a prominent figure in the field of cell therapy development and manufacturing. As the Senior Vice President and Head of Cell Therapy Development and Manufacturing at Sumitomo Pharma America, he oversees all aspects of Chemistry, Manufacturing, and Controls (CMC), including process development, analytical development, clinical and commercial manufacturing, and external development. Dr. McNeill has over 25 years of experience in the development and manufacturing of complex biologics, having worked with multiple startups and established organizations. He holds a Ph.D. in Molecular Physiology and Biophysics from Vanderbilt University.